Alpine Immune Sciences, Inc.

NasdaqGM:ALPN 株式レポート

時価総額:US$4.5b

Alpine Immune Sciences マネジメント

マネジメント 基準チェック /34

Alpine Immune Sciencesの CEO はMitch Goldで、 Jun2016年に任命され、 の在任期間は 7.92年です。 の年間総報酬は$ 2.92Mで、 20.5%給与と79.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.019%を直接所有しており、その価値は$ 860.60K 。経営陣と取締役会の平均在任期間はそれぞれ4.3年と6.1年です。

主要情報

Mitch Gold

最高経営責任者

US$2.9m

報酬総額

CEO給与比率20.5%
CEO在任期間7.9yrs
CEOの所有権0.02%
経営陣の平均在職期間4.3yrs
取締役会の平均在任期間6.1yrs

経営陣の近況

Recent updates

Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement

Apr 11

Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Mar 21
Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation

Mar 20
Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation

Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug

Mar 07

Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) Shares Climb 41% But Its Business Is Yet to Catch Up

Feb 07
Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) Shares Climb 41% But Its Business Is Yet to Catch Up

Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) 41% Share Price Surge Not Quite Adding Up

Dec 19
Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) 41% Share Price Surge Not Quite Adding Up

We Think Alpine Immune Sciences (NASDAQ:ALPN) Can Afford To Drive Business Growth

Sep 23
We Think Alpine Immune Sciences (NASDAQ:ALPN) Can Afford To Drive Business Growth

Revenues Not Telling The Story For Alpine Immune Sciences, Inc. (NASDAQ:ALPN)

May 11
Revenues Not Telling The Story For Alpine Immune Sciences, Inc. (NASDAQ:ALPN)

Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?

Dec 12
Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?

Alpine Immune Sciences drops 13% after hours on $100M stock offering

Sep 20

Despite Lacking Profits Alpine Immune Sciences (NASDAQ:ALPN) Seems To Be On Top Of Its Debt

Aug 09
Despite Lacking Profits Alpine Immune Sciences (NASDAQ:ALPN) Seems To Be On Top Of Its Debt

Alpine: Rest Before Rallying Again

Apr 25

Is Alpine Immune Sciences (NASDAQ:ALPN) A Risky Investment?

Apr 12
Is Alpine Immune Sciences (NASDAQ:ALPN) A Risky Investment?

Rock star Growth Puts Alpine Immune Sciences (NASDAQ:ALPN) In A Position To Use Debt

Sep 18
Rock star Growth Puts Alpine Immune Sciences (NASDAQ:ALPN) In A Position To Use Debt

Industry Analysts Just Upgraded Their Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Revenue Forecasts By 42%

Aug 18
Industry Analysts Just Upgraded Their Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Revenue Forecasts By 42%

CEO報酬分析

Alpine Immune Sciences の収益と比較して、Mitch Gold の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$37m

Dec 31 2023US$3mUS$599k

-US$32m

Sep 30 2023n/an/a

-US$57m

Jun 30 2023n/an/a

-US$59m

Mar 31 2023n/an/a

-US$64m

Dec 31 2022US$3mUS$544k

-US$58m

Sep 30 2022n/an/a

-US$54m

Jun 30 2022n/an/a

-US$54m

Mar 31 2022n/an/a

-US$47m

Dec 31 2021US$3mUS$523k

-US$50m

Sep 30 2021n/an/a

-US$42m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$1mUS$500k

-US$28m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$33m

Mar 31 2020n/an/a

-US$35m

Dec 31 2019US$2mUS$485k

-US$42m

Sep 30 2019n/an/a

-US$47m

Jun 30 2019n/an/a

-US$48m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$1mUS$400k

-US$36m

Sep 30 2018n/an/a

-US$30m

Jun 30 2018n/an/a

-US$15m

Mar 31 2018n/an/a

-US$11m

Dec 31 2017US$2mUS$300k

-US$8m

報酬と市場: Mitchの 総報酬 ($USD 2.92M ) は、 US市場 ($USD 6.60M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Mitchの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Mitch Gold (55 yo)

7.9yrs

在職期間

US$2,921,224

報酬

Dr. Mitchell H. Gold, also known as Mitch, M.D., has been Executive Chairman and Chief Executive Officer at Alpine Immune Sciences Inc. since January 2015 and June 2016 respectively. Dr. Gold served as the...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Mitchell Gold
Executive Chairman & CEO7.9yrsUS$2.92m0.019%
$ 860.6k
Stanford Peng
President and Head of Research & Development5.1yrsUS$1.75m0.43%
$ 19.2m
Paul Rickey
Senior VP7.1yrsUS$1.28mデータなし
Ulrich Fuhs
VP of Finance & Chief Accounting Officerless than a yearデータなし0.044%
$ 2.0m
M. Yi
Chief Technology Officerless than a yearデータなしデータなし
Michelle Greenblatt
Director of Investor Relations & Corporate Communicationsno dataデータなしデータなし
Remy Durand
Chief Business Officer4.3yrsデータなし0.15%
$ 6.6m
Andrew Sandler
Chief Medical Officer1.8yrsデータなしデータなし

4.3yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: ALPNの経営陣は 経験豊富 であると考えられます ( 4.3年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Mitchell Gold
Executive Chairman & CEO9.3yrsUS$2.92m0.019%
$ 860.6k
Robert Conway
Independent Director6.8yrsUS$110.21k0.073%
$ 3.2m
James Topper
Independent Director7.9yrsUS$101.46k0%
$ 0
Peter Thompson
Independent Director7.9yrsUS$103.96k0%
$ 0
Rafi Ahmed
Member of Scientific Advisory Board5.5yrsデータなしデータなし
Xiangmin Cui
Independent Director5.3yrsUS$100.21k0%
$ 0
Andrew Scharenberg
Scientific Advisory Board Chairmanno dataデータなしデータなし
Christopher Peetz
Independent Director6.1yrsUS$98.96k0.0028%
$ 123.5k
John Thompson
Member of Scientific Advisory Board5.5yrsデータなしデータなし
Manish Butte
Member of Scientific Advisory Boardno dataデータなしデータなし
Paul Tumeh
Member of Scientific Advisory Boardno dataデータなしデータなし
James Welsh
Member of Scientific Advisory Board5.5yrsデータなしデータなし

6.1yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: ALPNの 取締役会経験豊富 であると考えられます ( 6.1年の平均在任期間)。